INTRODUCTION
Several parameters are thought to be beneficial to enhance neocartilage formation and engineered tissue quality including mechanical stimulation and increased medium perfusion (1). However, there is little account of the effect on cartilage formation when combining these parameters, especially with human articular (HAC) chondrocytes. Hence, in this current study we utilized a bioreactor system to generate perfusion during unconfined compression of HAC in alginate and analyzed cartilage specific gene expression and glycosaminoglycan (GAG) production levels. METHODS Chondrocyte culture: Human articular cartilage was obtained from tissue banks. Chondrocytes from nine donors (age range 14-55 yo, 2 female and 7 male) were isolated via enzymatic digestion and passaged once in monolayer culture. HAC were suspended in 2% alginate (8x10 6 cells per ml) and crosslinked into slabs using CaCl 2 . 6mm disks were cut using a dermal punch and cultured in a commercial bioreactor system which provided cyclic compressive strain and simultaneous culture medium perfusion in nine different wells (DynaGen, Tissue Growth Technologies; Figure 1A ). Treatment conditions: For each donor, three conditions were tested over 7 and 14 days. Free swelling samples (FS, controls) were maintained in 6 well plates with 10ml of ITS+ medium, supplemented with TGF1 (10ng/ml). Two bioreactor conditions were defined: i) perfusion only (P), 100l/per minute; and ii) perfusion and loading (P/L) 20% dynamic compressive loading using a sine wave at 0.5 Hz for one hour per day. Force displacement curves were monitored throughout the experiment ( Figure 1C ). The circulating medium volume through the bioreactor was 70ml which was changed every 3-4 days. Outcome measurements: Calcein AM and Ethidium Homodimer-1 (Invitrogen) were used to detect live and dead cells, respectively, using a laser confocal microscope. RNA was isolated and reverse transcribed for expression of Col2a1, AGGRECAN, Col6a1, PRG4, CCL20, MMP3 and iNOS relative to GAPDH. Total GAG was assessed using a modified DMMB assay (2). The CyQUANT assay kit (Invitrogen) was used to determine DNA content. GAG measurements are expressed relative to DNA content. After 14 days of culture, alginate gels from each condition were cultured in ITS+ medium with 35 S for a further 48 hours to measure 35 S incorporation into GAG (3). Equilibrium gel stiffness (4) was measured at 5% incremental strains (up to 20%) in a custom electromagnetic device (SMAC). RESULTS Cell viability was consistently high (80 5.2%). No significant differences in gel stiffness were detected between each treatment group. Col2a1 mRNA expression levels were significantly higher (at least 3-fold; P<0.05) in both bioreactor conditions compared to FS by day 7 and 14 ( Figure 2A) . For all genes studies, no significant differences were seen between P only and PL samples. A trend of higher Col6a1 expression in the P group compared to PL was observed. MMP3 gene expression was 4-fold higher in both P and PL compared to FS by day 7, which increased to10-fold by day 14 ( Figure 1B) . Compared to FS, iNOS expression levels were 4-7-fold higher in P and PL by day 7, respectively. By day 14, iNOS levels had decreased to approximately 2-fold less that the FS condition ( Figure 2B ). Aggrecan mRNA levels were not significantly altered in any condition ( Figure 1A ), although both GAG/DNA and 35S GAG incorporation studies indicated higher GAG retention and synthesis in the FS treatments ( Figure 3A and 3B) . 
DISCUSSION
Our data indicates that conditions created in the bioreactor enhanced Col2a1 and Col6a1 gene expression compared to free-swelling. No significant effect of combining perfusion and load over perfusion only was detected in any measured parameter. Aggrecan was not significantly altered between all conditions. Yet, free-swelling conditions lead to higher accumulation of GAG, which is likely a reflection of increased MMP3 activity (5) in the bioreactor cultured samples and/or as a consequence of the action of perfusion (6). Decreased iNOS indicates that perfusion may decrease inflammatory response, perhaps by removing normally accumulated factors that stimulate its expression like IL-1 and TNF (7). The mixed results here indicate a need to study timing of perfusion, loading and free-swelling conditions. For instance, it may be better to perfuse medium for the first 7 days, then culture in free-swelling for an additional 7 days to permit GAG accumulation. There after, loading may further stimulate ECM production. Intermittent loading regimes have significant effects on ECM production (8). Acknowledgements Funding provided by NIH/NIAMS P01 AG007996. REFERENCES 1. Concaro S, et al. 2009. Adv Biochem Eng Biotechnol. 112:125-43 ; 2. Enobakhare BO, et al. 1996. Anal Biochem. 243 (1):189-91; 3. Legendre et al. 2008. Osteo. Cart. 16:105-14 
